Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Nephrology

Hematology/Oncology

Survival outcomes for advanced kidney cancer patients in the era of targeted therapies

Annals of Translational Medicine | May 25, 2018 Hematology/Oncology

Usefulness of oral ferric citrate in patients with iron-deficiency anemia and chronic kidney disease with or without heart failure

The American Journal of Cardiology | May 24, 2018 Hematology/Oncology

Identification of risk factors in high-dose methotrexate-induced acute kidney injury in childhood acute lymphoblastic leukemia

Chemotherapy | May 09, 2018 Hematology/Oncology

Treatment of stage IV favorable histology Wilms tumor with lung metastases: A report from the children’s oncology group AREN0533 study

Journal of Clinical Oncology | May 04, 2018 Hematology/Oncology

Oral vs intravenous iron supplementation for the treatment of iron deficiency anemia in patients on maintenance hemodialysis—effect on fibroblast growth factor-23 metabolism

Journal of Renal Nutrition | May 01, 2018 Hematology/Oncology

Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: Emphasis on partial nephrectomy

BMC Cancer | Apr 23, 2018 Hematology/Oncology

Multi-institutional survival analysis of incidental pathologic T3a upstaging in clinical T1 renal cell carcinoma following partial nephrectomy

Urology | Apr 22, 2018 Hematology/Oncology

Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis

Urologic Oncology: Seminars and Original Investigations | Apr 21, 2018 Hematology/Oncology

What is the risk of local recurrence after laparoscopic transperitoneal radical nephrectomy in children with Wilms tumours? Analysis of a local series and review of the literature

Journal of Pediatric Urology | Apr 20, 2018 Hematology/Oncology

Phase II study of two weeks on, one week off sunitinib scheduling in patients with metastatic renal cell carcinoma

Journal of Clinical Oncology | Apr 18, 2018 Hematology/Oncology

« Prev 1 … 16 17 18 19 20 … 29 Next »

Survival outcomes for advanced kidney cancer patients in the era of targeted therapies

Usefulness of oral ferric citrate in patients with iron-deficiency anemia and chronic kidney disease with or without heart failure

Identification of risk factors in high-dose methotrexate-induced acute kidney injury in childhood acute lymphoblastic leukemia

Treatment of stage IV favorable histology Wilms tumor with lung metastases: A report from the children’s oncology group AREN0533 study

Oral vs intravenous iron supplementation for the treatment of iron deficiency anemia in patients on maintenance hemodialysis—effect on fibroblast growth factor-23 metabolism

Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: Emphasis on partial nephrectomy

Multi-institutional survival analysis of incidental pathologic T3a upstaging in clinical T1 renal cell carcinoma following partial nephrectomy

Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis

What is the risk of local recurrence after laparoscopic transperitoneal radical nephrectomy in children with Wilms tumours? Analysis of a local series and review of the literature

Phase II study of two weeks on, one week off sunitinib scheduling in patients with metastatic renal cell carcinoma

Myxoid Treatment in Alternative Medicine

Recent Advances in Local Anaesthesia

Managing Obesity: Understanding the Basics

Comprehensive Management of Vesicovaginal Fistula

MIP: Role of Neurocritical Care in Stroke Management: Dr Nidhal

Survival outcomes for advanced kidney cancer patients in the era of targeted therapies

Usefulness of oral ferric citrate in patients with iron-deficiency anemia and chronic kidney disease with or without heart failure

Identification of risk factors in high-dose methotrexate-induced acute kidney injury in childhood acute lymphoblastic leukemia

Treatment of stage IV favorable histology Wilms tumor with lung metastases: A report from the children’s oncology group AREN0533 study

Oral vs intravenous iron supplementation for the treatment of iron deficiency anemia in patients on maintenance hemodialysis—effect on fibroblast growth factor-23 metabolism

Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: Emphasis on partial nephrectomy

Multi-institutional survival analysis of incidental pathologic T3a upstaging in clinical T1 renal cell carcinoma following partial nephrectomy

Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis

What is the risk of local recurrence after laparoscopic transperitoneal radical nephrectomy in children with Wilms tumours? Analysis of a local series and review of the literature

Phase II study of two weeks on, one week off sunitinib scheduling in patients with metastatic renal cell carcinoma

Myxoid Treatment in Alternative Medicine

Recent Advances in Local Anaesthesia

Managing Obesity: Understanding the Basics

Comprehensive Management of Vesicovaginal Fistula

MIP: Role of Neurocritical Care in Stroke Management: Dr Nidhal

Select Specialty

Select Topic